In April 2025, the U.S. Food and Drug Administration (FDA) announced a groundbreaking initiative to phase out the animal testing requirement for monoclonal antibodies and other drugs. This marked a significant milestone in the advancement of preclinical research. Experts from regulatory agencies, academia, and industry worldwide convened to promote the adoption of New Approach Methodologies […]
VitroGel® takes the fight to fibrosis—making cell invasion studies faster, clearer, and more reliable. Pulmonary fibrosis, especially when triggered by toxins such as paraquat, is a life-threatening condition driven by inflammation, epithelial-mesenchymal transition (EMT), and invasive cell behavior. To understand and halt this progression, researchers require a physiologically relevant in vitro system that can mimic […]
Introduction Spheroid invasion assays offer a physiologically relevant three-dimensional (3D) in vitro model for studying cancer cell behavior, surpassing the limitations of traditional two-dimensional (2D) cultures [1]. Spheroids are compact cell aggregates that recapitulate critical in vivo features, including cell–cell and cell–matrix interactions, as well as nutrient and oxygen gradients providing a more accurate representation […]
TheWell Bioscience Unveils VitroGel® NEURON: A Breakthrough in 3D and 2D Neuron Culture TheWell Bioscience proudly launches VitroGel® NEURON, a ready-to-use, xeno-free hydrogel system designed to support both 2D and 3D cultures of neural stem cells and neurons. This innovative product aims to provide researchers with an animal-free, reliable, and consistent platform for neural cell […]
